Aurenar Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.7M

  • Investors
  • 10

Aurenar General Information

Description

Manufacturer of neuromodulation devices intended to treat inflammatory conditions in intensive care patients. The company develops non-invasive, ear-worn stimulation devices that modulate neural pathways associated with inflammatory responses, enabling healthcare providers to manage complications and improve patient outcomes.

Contact Information

Website
www.aurenar.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saint Louis, MO
  • United States
Primary Industry
Therapeutic Devices
Vertical(s)
HealthTech
Corporate Office
  • Saint Louis, MO
  • United States

Aurenar Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aurenar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 28-Jul-2026 $5.7M Completed Startup
1. Seed Round 01-Nov-2024 Completed Startup
To view Aurenar’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Aurenar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aurenar Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
American Heart Association Ventures Corporate Venture Capital Minority
BJC HealthCare Corporation Minority
Kaleida Capital Venture Capital Minority
NuFund Venture Group Angel Group Minority
Solas BioVentures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Aurenar FAQs

  • When was Aurenar founded?

    Aurenar was founded in 2023.

  • Where is Aurenar headquartered?

    Aurenar is headquartered in Saint Louis, MO.

  • What is the size of Aurenar?

    Aurenar has 10 total employees.

  • What industry is Aurenar in?

    Aurenar’s primary industry is Therapeutic Devices.

  • Is Aurenar a private or public company?

    Aurenar is a Private company.

  • What is the current valuation of Aurenar?

    The current valuation of Aurenar is .

  • What is Aurenar’s current revenue?

    The current revenue for Aurenar is .

  • How much funding has Aurenar raised over time?

    Aurenar has raised $5.7M.

  • Who are Aurenar’s investors?

    American Heart Association Ventures, BJC HealthCare, Kaleida Capital, NuFund Venture Group, and Solas BioVentures are 5 of 10 investors who have invested in Aurenar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process